Thin film block copolymer self-assembly for nanophotonics.

Kulkarni AA, Doerk GS

Exceptional response to afatinib in a patient with persistent G719A EGFR-mutant NSCLC.

Kulkarni AA, Fujioka N, Reinhardt L, Patel MR, Kratzke RA

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer.

Fu J, Reid SA, French B, Hennessy C, Hwang C, Gatson NT, Duma N, Mishra S, Nguyen R, Hawley JE, Singh SRK, Chism DD, Venepalli NK, Warner JL, Choueiri TK, Schmidt AL, Fecher LA, Girard JE, Bilen MA, Ravindranathan D, Goyal S, Wise-Draper TM, Park C, Painter CA, McGlown SM, de Lima Lopes G Jr, Serrano OK, Shah DP, COVID-19 and Cancer Consortium (CCC19)

A Turning Point for Mesothelioma Therapy.

Kulkarni AA, Kratzke RA

Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States.

Hawley JE, Sun T, Chism DD, Duma N, Fu JC, Gatson NTN, Mishra S, Nguyen RH, Reid SA, Serrano OK, Singh SRK, Venepalli NK, Bakouny Z, Bashir B, Bilen MA, Caimi PF, Choueiri TK, Dawsey SJ, Fecher LA, Flora DB, Friese CR, Glover MJ, Gonzalez CJ, Goyal S, Halfdanarson TR, Hershman DL, Khan H, Labaki C, Lewis MA, McKay RR, Messing I, Pennell NA, Puc M, Ravindranathan D, Rhodes TD, Rivera AV, Roller J, Schwartz GK, Shah SA, Shaya JA, Streckfuss M, Thompson MA, Wulff-Burchfield EM, Xie Z, Yu PP, Warner JL, Shah DP, French B, Hwang C, COVID-19 and Cancer Consortium (CCC19)

Multi-Step Synthesis of Miltefosine: Integration of Flow Chemistry with Continuous Mechanochemistry.

Patil NB, Atapalkar RS, Chavan SP, Kulkarni AA

Rational combination of an immune checkpoint inhibitor with CSF1R inhibitor-loaded nanoparticle enhances anticancer efficacy.

Ramesh A, Malik V, Ranjani HA, Smith H, Kulkarni AA

Risk for stroke and myocardial infarction with abiraterone versus enzalutamide in metastatic prostate cancer patients.

Kulkarni AA, Rubin N, Tholkes A, Shah S, Ryan CJ, Lutsey PL, Prizment A, Rao A

The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19.

Li A, Kuderer NM, Hsu CY, Shyr Y, Warner JL, Shah DP, Kumar V, Shah S, Kulkarni AA, Fu J, Gulati S, Zon RL, Li M, Desai A, Egan PC, Bakouny Z, Kc D, Hwang C, Akpan IJ, McKay RR, Girard J, Schmidt AL, Halmos B, Thompson MA, Patel JM, Pennell NA, Peters S, Elshoury A, de Lima Lopes G, Stover DG, Grivas P, Rini BI, Painter CA, Mishra S, Connors JM, Lyman GH, Rosovsky RP, CCC19 consortium

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19.

Thompson MA, Henderson JP, Shah PK, Rubinstein SM, Joyner MJ, Choueiri TK, Flora DB, Griffiths EA, Gulati AP, Hwang C, Koshkin VS, Papadopoulos EB, Robilotti EV, Su CT, Wulff-Burchfield EM, Xie Z, Yu PP, Mishra S, Senefeld JW, Shah DP, Warner JL, COVID-19 and Cancer Consortium

Electrodeposition of atmosphere-sensitive ternary sodium transition metal oxide films for sodium-based electrochemical energy storage.

Patra A, Davis J 3rd, Pidaparthy S, Karigerasi MH, Zahiri B, Kulkarni AA, Caple MA, Shoemaker DP, Zuo JM, Braun PV

Impact of diabetes mellitus on morbidity and survival after pancreaticoduodenectomy for malignancy.

Deo KB, Kulkarni AA, Kumar-M P, Krishnamurthy G, Shenvi S, Rana SS, Kapoor R, Gupta R

Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer.

Zhang S, Pease DF, Kulkarni AA, Kumar M, Shanley RM, Xu B, Joshi SP, Patel MR

Persistent Disparities in Immunization Rates for the Seven-Vaccine Series Among Infants 19-35 Months in the United States.

Kulkarni AA, Desai RP, AlcalĂĄ HE, Balkrishnan R

Engineered Multifunctional Nano- and Biological Materials for Cancer Immunotherapy.

Brouillard A, Deshpande N, Kulkarni AA